San Francisco Professional Events List


Oncology Commercialization & Market Access


Date
Feb 28, 2017 - 07:30 AM - Mar 01, 02:30 PM
Organizer
CBI
Venue
Hyatt Centric Fisherman's Wharf
Location
555, North Pt

StreetSan Francisco,
CA,
USA,
ZIP: 94133
Phone: (888) 421-1442

Determine Cost Value Differentiation to Enable Market Access and Product Uptake

The oncology marketplace is an increasingly competitive environment and a strong commercialization strategy and launch plan is essential for product success. As new, innovative therapies enter the pipeline, how do you ensure that your products attain market access?

Join us at CBI’s 10th Annual Oncology Commercialization & Market Access — an in-depth and dynamic event delivering content designed to help you build a commercial playbook, drive a successful launch and enhance oncology commercialization strategies already in place. Learn how you can set your brand apart in the changing payment model landscape and gain tactical advice on how to best position your brand.

Learn from Industry Leaders in Oncology to:

  • Develop and define product value for high-cost novel therapies
  • Explore cost integration into evidence-based medicine to define value
  • Discuss motivating influences behind therapy adoption with providers and payers
  • Examine key internal business considerations to successfully execute a global product launch
  • Incorporate medical affairs to bridge development and commercialization and ensure launch success
  • Cultivate methods to partner products with CDx during the therapy development stage to justify process and highlight value
  • Understand the dynamic payer landscape in the U.S. and Europe to drive global product access

Who Should Attend

You will benefit from attending this event if you are an executive or senior level director from the oncology, pharmaceutical or biotech industries with responsibilities or involvement in the following areas:

  • Commercialization
  • Commercial Operations
  • Oncology/Therapeutic Lead
  • National Accounts/Account Management
  • Reimbursement
  • Market Access
  • Payer Strategy
  • Marketing

This conference also benefits specialty pharmacies and distributors, reimbursement and market access consultants, oncology marketing and commercialization solution providers.

A GREAT PLACE TO MEET YOUR MARKET!

Take advantage of the best opportunity to meet potential clients face-to-face.
Build relationships while demonstrating thought leadership and sharing expertise.
For more information on how to position your company as a sponsor or exhibitor, contact
Jamie McHugh at 339-298-2106 or email [email protected].

Advantage Rate
Register by 01/20/2017
Standard Rate
Register by 02/27/2017
Onsite Rate
Register Onsite
$1899 $2199 $2299  

PLEASE NOTE: All advertised discounts are taken from the full, Standard Rate.



Agenda


DAY ONE TUESDAY, FEBRUARY 28, 2017

7:30

Registration and Continental Breakfast

8:30

Workshop Leader’s Welcome and Opening Remarks

8:45

IN-CONFERENCE WORKSHOP

Build a Cohesive Oncology Pre-Launch Planning Strategy in Anticipation of FDA Drug Approval

New product launches are becoming more difficult as more drugs begin to enter the highly saturated oncology market. In this high-risk, high-reward arena, it is important to realize that there is no “one size fits all” model for launching new oncology products. However, to increase the chance of success, there are best practices that can be streamlined — from a commercial, medical, HEOR and advocacy perspective — to ensure launch success.

I.Align Both Internal and External Goals to Enhance Collaboration

II.Commercial Preparedness

Workshop Leader:

Ammar Qadan
Vice President, Global Market Access
Illumina

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Networking Luncheon

1:15

Chairperson’s Welcome and Opening Remarks

Sunil Joshi
President & CEO
Gradalis

Navigate Emerging Trends and Industry Initiatives to Maximize Commercial Success

1:30

OPENING KEYNOTE PANEL DISCUSSION
Peeking Behind the Curtain —
Navigate Through New and Alternative Payment Models to Improve Patient Care and Align Provider Payments with Value

MODERATOR:

Don Sharpe
Founder & Publisher
Oncology Business Review (OBR)

PANELISTS:

Matthew Farber
Senior Director, Oncology Disease State
Walgreens Co.

Sunil Joshi
President & CEO
Gradalis

R’Kes D. Starling, RPh, MBA
Vice President, Specialty Pharmacy
McKesson Specialty Health

2:15

FEATURED ADDRESS
A Patient’s Perspective on Access

Bert E. Thomas IV, PhD, MBA
Chief Executive Officer
Sarcoma Foundation of America (SFA)

3:00

Networking and Refreshment Break

3:30

The Future of Oncology Value Frameworks —
Understanding their Impact on Drug Pricing in Oncology

MODERATOR:

Leora Schiff
Principal
Altius Strategy Consulting

PANELISTS:

Clark Paramore
Head of Value Demonstration
bluebird bio

Martin J. Zagari, MD
Vice President, Global Health Economics
Amgen

4:15

Mapping the Product Journey —Successes and Lessons Learned from Multi-Stakeholder Collaborations

Melissa Paige
Pharmacy Patient Medication Principal Coordinator,
Emily Couric Clinical Cancer Center
University of Virginia Health System

5:00

Close of Day One

Networking, Wine and Cheese Receptionimmediately following the final session on day one

DAY TWO WEDNESDAY, MARCH 1, 2017

8:00

Continental Breakfast

8:30

Chairman’s Review of Day One

Sunil Joshi
President & CEO
Gradalis

Develop a Strong Product Value Story to Enhance Market Access Strategies

8:45

Oncology Clinical Pathways Commercialization Opportunity Landscape

Todd Antonelli
Managing Director, Strategy
Berkeley Research Group, LLC

9:30

Access and Value for Combination (immuno)oncology Therapy…
The Forest and the Trees

Reg Waldeck
Vice President Access, Pricing & Health Economics
Celldex

10:15

Networking and Refreshment Break

10:45

CASE STUDY
Utilize Big Data to Demonstrate Product Value and Drive Market Access

Omar Dabbous
Head of HEOR and Value
Halozyme Therapeutics Inc.

11:30

MULTI-STAKEHOLDER PANEL DISCUSSION
Understand Pricing, Reimbursement and Market Access for
Oncology Products in a Changing Reimbursement Landscape

MODERATOR:

Leora Schiff
Principal
Altius Strategy Consulting

PANELISTS:

Chris Mancill
Vice President, Reimbursement-Oncology
EMD Serono

Scott Megaffin
President
Churchill Pharmaceuticals LLC

Michael D. Miller, MD
Healthcare and Life Sciences Consultant
HealthPolCom

Robert Popovian, PharmD, MS
Vice President, US Government Relations
Pfizer Inc

12:30

Networking Luncheon

1:30

Build Strategies to Infuse the Clinical Development Process with a Compelling Value Proposition and Story

Julie C. Locklear, PharmD, MBA
Vice President and Head, Health Economics & Outcomes Research, Medical
EMD Serono

2:15

Closing Remarks — Top Takeaways from the Chair

Sunil Joshi
President & CEO
Gradalis

2:30

Close of Conference



Speaker Details


 

Todd Antonelli
Managing Director, Strategy
Berkeley Research Group, LLC

Omar Dabbous
Head of HEOR and Value
Halozyme Therapeutics Inc.

Matthew Farber
Senior Director, Oncology Disease State
Walgreens Co.

Sunil Joshi
President & CEO
Gradalis

Julie C. Locklear, PharmD, MBA
Vice President and Head,
Health Economics & Outcomes Research, Medical
EMD Serono

Chris Mancill
Vice President, Reimbursement-Oncology
EMD Serono

Scott Megaffin
President
Churchill Pharmaceuticals LLC

Michael D. Miller, MD
Healthcare and Life Sciences Consultant
HealthPolCom

Melissa Paige
Pharmacy Patient Medication Principal Coordinator,
Emily Couric Clinical Cancer Center
University of Virginia Health System

Clark Paramore
Head of Value Demonstration
bluebird bio

Robert Popovian, PharmD, MS
Vice President, US Government Relations
Pfizer Inc

Ammar Qadan
Vice President, Global Market Access
Illumina

Leora Schiff
Principal
Altius Strategy Consulting

Don Sharpe
Founder & Publisher
Oncology Business Review (OBR)

R’Kes D. Starling, RPh, MBA
Vice President, Specialty Pharmacy
McKesson Specialty Health

Bert E. Thomas IV, PhD, MBA
Chief Executive Officer
Sarcoma Foundation of America (SFA)

Reg Waldeck
Vice President Access, Pricing & Health Economics
Celldex

Martin J. Zagari, MD
Vice President, Global Health Economics
Amgen


Event Categories
Keywords: access , Book , business , conference , design , development , dynamic, environment, industry , lear




Comments








Events Calendar

SunMonTueWedThuFriSat
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 1 2 3 4

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99